0000899243-21-018410.txt : 20210505 0000899243-21-018410.hdr.sgml : 20210505 20210505185008 ACCESSION NUMBER: 0000899243-21-018410 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210503 FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RATH HENRY C. CENTRAL INDEX KEY: 0001859736 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38459 FILM NUMBER: 21895090 MAIL ADDRESS: STREET 1: C/O SURFACE ONCOLOGY, INC. STREET 2: 50 HAMPSHIRE STREET 8TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Surface Oncology, Inc. CENTRAL INDEX KEY: 0001718108 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-714-4096 MAIL ADDRESS: STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-03 0 0001718108 Surface Oncology, Inc. SURF 0001859736 RATH HENRY C. C/O SURFACE ONCOLOGY, INC., 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 0 1 0 0 Chief Business Officer Stock Option (Right to Buy) 7.33 2021-05-03 4 A 0 140000 0.00 A 2031-05-03 Common Stock 140000 140000 D This option shall vest as follows: 25% of the shares shall vest on April 26, 2022, and the remaining shares shall vest in 36 equal monthly installments, so long as the reporting person remains an employee or other service provider of the Company on such dates. /s/ Jessica Fees, as Attorney-in-Fact 2021-05-05